Skip to content

Alkermes ALKS Treasury Stock

Treasury Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.52B-0.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$53.19M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$405.78M+25.5%
Royalty Pharma logo
Royalty PharmaRPRX
$2.71M+2.1%
Viatris logo
ViatrisVTRS
$1.01B+48.1%
Biogen logo
BiogenBIIB
$2.98B0.0%

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's treasury stock?
Alkermes (ALKS) reported treasury stock of $501.43M in Q1 2026.
How has Alkermes's treasury stock changed year-over-year?
Alkermes's treasury stock increased by 11.9% year-over-year, from $448.04M to $501.43M.
What is the long-term trend for Alkermes's treasury stock?
Over 5 years (2020 to 2025), Alkermes's treasury stock has grown at a 29.0% compound annual growth rate (CAGR), from $126.09M to $450.29M.
What does treasury stock mean?
The value of shares the company has bought back from the market.
How do you interpret treasury stock?
An increase indicates active share buyback programs, often signaling management's confidence in the stock or an effort to offset dilution.
How does treasury stock compare across companies?
Commonly used by mature biotech companies to manage earnings per share and return excess cash.